United States
The article provides a brief overview of the existing legal framework associated with the third-party review.
United States
The new article highlights the aspects related to how the regulatory context should be considered when assessing real-world evidence and real-world data.
FDA
The article provides a brief overview of the approach to be followed for the reports related to studies and reports associated with it.
FDA
The present article describes in detail the policy followed by the authority concerning specific supplements.
FDA
The article highlights the key points associated with the electronic submissions template described by the US authority.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now
